Imbruvica — Cigna
Primary Central Nervous System Lymphoma
Initial criteria
- Patient age ≥ 18 years
- According to the prescriber, the patient is not a candidate for or is intolerant to high-dose methotrexate OR Patient has tried at least one therapy
Approval duration
1 year